top of page
NM.jpg

IN THE STATES

NEW MEXICO

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs and  economic impact data, clinical trial data, and vendor/supplier data from 16 biopharmaceutical companies regarding their business relationships with vendors and the total expenditures paid to vendors in New Mexico.

NM.png

Economic
Output

$2.2B

Direct Jobs Supported by the Industry

2,198

Total Jobs Supported

7,300

State Total Vendor Relationships

172

State Total Vendor Spending

$28,424,607

Total Clinical
Trials

232

Dollar Amount Invested

$53.4M

Clinical Trial Participants

3,536

Total Economic Impact

$126M

bottom of page